Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Uniqure
Uniqure
(QURE)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Glybera
Alipogene tiparvovec
2012-10-25
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Alipogene tiparvovec
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemias
Mycophenolate sodium
immunosuppression therapy
,
healthy volunteers/patients
,
vasculitis
,
microscopic polyangiitis
,
systemic vasculitis
,
congenital abnormalities
,
urologic diseases
,
chronic kidney failure
,
systemic scleroderma
,
localized scleroderma
,
diffuse scleroderma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
diabetes mellitus
,
hypoglycemia
,
lung diseases
,
interstitial lung diseases
,
hypertension
,
iga glomerulonephritis
,
renal hypertension
,
bullous pemphigoid
,
psoriasis
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
type 1 diabetes mellitus
,
neuromyelitis optica
,
pemphigus
,
myasthenia gravis
,
muscle weakness
,
diabetic nephropathies
,
glomerulonephritis
,
multiple sclerosis
,
sclerosis
,
cardiovascular diseases
,
lung transplantation
,
sarcoidosis
,
pulmonary sarcoidosis
,
membranous glomerulonephritis
,
kidney transplantation
,
kidney diseases
,
liver transplantation
,
heart transplantation
,
renal insufficiency
,
polyomavirus infections
,
corneal transplantation
,
liver diseases
,
hiv infections
,
graft vs host disease
,
hematopoietic stem cell transplantation
Alfacalcidol
healthy volunteers/patients
,
renal cell carcinoma
,
carcinoma
,
muscular atrophy
,
spinal muscular atrophy
,
neoplasms
,
melanoma
,
uterine cervical neoplasms
,
anemia
,
chronic hepatitis d
,
hepatitis d
,
rheumatoid arthritis
,
arthritis
,
hepatitis
,
hepatitis a
,
hepatitis c
,
chronic hepatitis c
,
chronic hepatitis
Solumedrol
non-hodgkin lymphoma
,
kidney transplantation
,
graft rejection
,
leukemia
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
multiple myeloma
,
plasma cell neoplasms
,
gout
,
juvenile arthritis
,
arthritis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use